Short Interest in First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Increases By 325.0%

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) was the target of a significant increase in short interest in the month of December. As of December 31st, there was short interest totaling 35,837 shares, an increase of 325.0% from the December 15th total of 8,433 shares. Based on an average trading volume of 16,981 shares, the short-interest ratio is currently 2.1 days. Approximately 0.6% of the company’s stock are sold short. Approximately 0.6% of the company’s stock are sold short. Based on an average trading volume of 16,981 shares, the short-interest ratio is currently 2.1 days.

First Trust NYSE Arca Biotechnology Index Fund Trading Up 0.3%

Shares of FBT stock traded up $0.59 on Wednesday, hitting $214.61. 14,863 shares of the stock were exchanged, compared to its average volume of 35,174. The firm has a market capitalization of $1.37 billion, a P/E ratio of 21.72 and a beta of 0.65. First Trust NYSE Arca Biotechnology Index Fund has a fifty-two week low of $141.38 and a fifty-two week high of $220.14. The business has a 50-day moving average of $208.52 and a 200 day moving average of $186.81.

Hedge Funds Weigh In On First Trust NYSE Arca Biotechnology Index Fund

Several hedge funds have recently modified their holdings of FBT. Kingstone Capital Partners Texas LLC increased its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 913,142.7% during the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 15,324,213 shares of the company’s stock worth $2,352,314,000 after purchasing an additional 15,322,535 shares during the last quarter. Arlington Financial Advisors LLC bought a new position in shares of First Trust NYSE Arca Biotechnology Index Fund in the 2nd quarter valued at about $4,309,000. Holistic Financial Partners raised its holdings in shares of First Trust NYSE Arca Biotechnology Index Fund by 209.5% in the 2nd quarter. Holistic Financial Partners now owns 17,922 shares of the company’s stock valued at $2,891,000 after purchasing an additional 12,131 shares during the period. Modern Wealth Management LLC lifted its stake in First Trust NYSE Arca Biotechnology Index Fund by 39.5% in the 2nd quarter. Modern Wealth Management LLC now owns 42,030 shares of the company’s stock valued at $6,781,000 after purchasing an additional 11,907 shares during the last quarter. Finally, Navellier & Associates Inc. acquired a new position in First Trust NYSE Arca Biotechnology Index Fund during the third quarter worth approximately $2,090,000.

About First Trust NYSE Arca Biotechnology Index Fund

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.